|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Concert Pharmaceuticals, Inc. (CNCE) |
|
|
$8.37 0.00 (0.00%) as of 4:30 Fri 3/3
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
47,940,000 |
| Market
Cap: |
401.26(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.37 - $8.37 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Concert Pharmaceuticals is a late-stage clinical biopharmaceutical company that is developing CTP-543, a Janus Kinase 1 and Janus Kinase 2 inhibitor that Co. discovered through the application of its DCE Platform® (deuterated chemical entity platform). Co. is evaluating CTP-543 in a Phase 3 clinical program for the treatment of alopecia areata, a serious autoimmune dermatological condition. In addition to its wholly-owned development programs, Co. has entered into collaborative arrangements with companies to develop deuterium-modified versions of their marketed products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
227,052 |
| Total Buy Value |
$0 |
$0 |
$0 |
$1,078,498 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
81,977 |
| Total Sell Value |
$0 |
$0 |
$0 |
$653,253 |
| Total People Sold |
0 |
0 |
0 |
6 |
| Total Sell Transactions |
0 |
0 |
0 |
14 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mcgowan Pauline |
VP, Finance |
• – – |
2015-03-11 |
4 |
OE |
$3.50 |
$20,906 |
D/D |
5,973 |
5,973 |
|
- |
|
| Mcgowan Pauline |
VP, Finance |
• – – |
2015-03-10 |
4 |
AS |
$13.90 |
$307,496 |
D/D |
(22,122) |
0 |
|
- |
|
| Mcgowan Pauline |
VP, Finance |
• – – |
2015-03-10 |
4 |
OE |
$1.13 |
$43,828 |
D/D |
22,122 |
7,079 |
|
- |
|
| Tung Roger D |
Chief Executive Officer |
• • – |
2015-02-17 |
4 |
OE |
$1.13 |
$32,199 |
D/D |
28,495 |
490,017 |
|
- |
|
| Tung Roger D |
Chief Executive Officer |
• • – |
2014-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
200 |
489,817 |
|
- |
|
| Three Arch Associates Iv Lp |
10% Owner |
– – • |
2014-11-18 |
4 |
S |
$12.29 |
$3,072,500 |
I/I |
(250,000) |
12,301 |
|
- |
|
| Jaeger Wilfred E |
Director |
– • • |
2014-11-18 |
4 |
S |
$12.29 |
$3,072,500 |
I/I |
(250,000) |
29,052 |
|
- |
|
| Aldrich Richard |
Director |
– • – |
2014-10-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
82,405 |
82,405 |
|
- |
|
| Aldrich Richard |
Director |
– • – |
2014-10-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
102,417 |
0 |
|
- |
|
| Aldrich Richard |
Director |
– • – |
2014-10-16 |
4 |
GA |
$0.00 |
$0 |
D/D |
20,012 |
306,975 |
|
- |
|
| Silverman Robert |
Senior VP, General Counsel |
• – – |
2014-05-29 |
4 |
OE |
$1.13 |
$22,600 |
D/D |
20,000 |
20,000 |
|
- |
|
| Stuart Nancy |
Chief Operating Officer |
• – – |
2014-05-29 |
4 |
OE |
$0.57 |
$5,700 |
D/D |
10,000 |
10,000 |
|
- |
|
| Tung Roger D |
Chief Executive Officer |
• • – |
2014-05-22 |
4 |
OE |
$1.13 |
$67,800 |
D/D |
60,000 |
461,522 |
|
- |
|
| Wierenga Wendall D |
Director |
– • – |
2014-03-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,389 |
|
- |
|
| Kaneko Yasunori |
10% Owner |
– – • |
2014-02-20 |
4 |
B |
$14.00 |
$2,100,000 |
I/I |
150,000 |
1,208,920 |
1.5 |
- |
|
| Kaneko Yasunori |
10% Owner |
– – • |
2014-02-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,026,548 |
1,058,920 |
|
- |
|
| Freund John Gordon |
Director |
– • • |
2014-02-20 |
4 |
B |
$14.00 |
$2,100,000 |
I/I |
150,000 |
1,208,920 |
2.25 |
- |
|
| Freund John Gordon |
Director |
– • • |
2014-02-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,026,548 |
1,058,920 |
|
- |
|
| Gross Phillip |
10% Owner |
– – • |
2014-02-20 |
4 |
A |
$0.00 |
$0 |
I/I |
495,575 |
510,147 |
|
- |
|
| Brookside Capital Partners Fund Lp |
10% Owner |
– – • |
2014-02-19 |
4 |
B |
$14.00 |
$4,900,000 |
I/I |
350,000 |
1,497,833 |
1.5 |
- |
|
| Brookside Capital Partners Fund Lp |
10% Owner |
– – • |
2014-02-19 |
4 |
A |
$0.00 |
$0 |
I/I |
1,115,044 |
1,147,833 |
|
- |
|
| Ratcliffe Liam |
10% Owner |
– – • |
2014-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
92,036 |
107,327 |
|
- |
|
| Wan Mark A |
10% Owner |
– – • |
2014-02-19 |
4 |
B |
$14.00 |
$1,449,000 |
I/I |
103,500 |
801,726 |
1.5 |
- |
|
| Wan Mark A |
10% Owner |
– – • |
2014-02-19 |
4 |
A |
$0.00 |
$0 |
I/I |
690,264 |
700,462 |
|
- |
|
| Wan Mark A |
10% Owner |
– – • |
2014-02-19 |
4 |
B |
$14.00 |
$1,449,000 |
I/I |
103,500 |
777,620 |
1.5 |
- |
|
279 Records found
|
|
Page 10 of 12 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
